93. Обеспечение безопасности иммунизаци. СП 3.3.2342-08
94. Vuocolo S, Balmer P, Gruber WC. Et al. Vaccination strategies for the prevention of meningococcal disease. //Hum Vaccin Immunother. 2018.- 4;14(5):1203-1215.
95. Dretler AW, Rouphael NG, Stephens DS. Progress toward the global control of Neisseria meningitidis: 21st century vaccines, current guidelines, and challenges for future vaccine development.// Hum Vaccin Immunother. 2018 4;14(5):1146-1160.
96. Pace, D., Gauci, C. & Barbara, C. The epidemiology of invasive meningococcal disease and the utility of vaccination in Malta. Eur J Clin Microbiol Infect Dis 39, 1885–1897 (2020)
97. Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet. 1974 Jul 13;2(7872):81-4.
98. Morray JP, Tyler DC, Jones TK, Stuntz JT, Lemire RJ. Coma scale for use in brain-injured children. Crit Care Med. 1984 12(12):1018-20.
99. Menichetti F. et al. Invasive meningococcal disease due to group C N. meningitidis ST11 (cc11): the tuscany cluster 2015–2016 //Vaccine. – 2018. – Т. 36. – №. 40. – С. 5962-5966